Mary Jane Ferraro
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria 27
- Applied Microbiology and Biotechnology top 0.02%
- Clinical Biochemistry top 0.01%
- Bacterial Identification and Susceptibility Testing 48
- Endocrinology top 0.05%
- Infectious Diseases top 0.05%
- Antimicrobial Resistance in Staphylococcus 39
-
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Streptococcal Infections and Treatments 21
-
- Infective Endocarditis Diagnosis and Management 14
- Pneumonia and Respiratory Infections 12
-
- Pharmaceutical and Antibiotic Environmental Impacts 8
- Co-authors
- James H. JorgensenKathryn L. RuoffGeorge M. EliopoulosJ H JorgensenJana M. SwensonFred C. TenoverRobert C. MoelleringJohn A. Branda
- Journals
- New England Journal of Medicine (7 papers)The Lancet (1 paper)Clinical Infectious Diseases (17 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Mary Jane Ferraro
124 papers receiving 29.2k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Molecular Medicine 9.8k
- Applied Microbiology and Biotechnology 2.0k
- Clinical Biochemistry 5.4k
- Endocrinology 3.6k
- Infectious Diseases 8.3k
Countries citing papers authored by Mary Jane Ferraro
This map shows the geographic impact of Mary Jane Ferraro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jane Ferraro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jane Ferraro more than expected).
Fields of papers citing papers by Mary Jane Ferraro
This network shows the impact of papers produced by Mary Jane Ferraro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jane Ferraro. The network helps show where Mary Jane Ferraro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Jane Ferraro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2015 | 66 | |
| 3 | Better Tests, Better Care: Improved Diagnostics for Infectious Diseasesbreakdown → | 2013 | 461 |
| 4 | 2013 | 74 | |
| 5 | 2013 | 110 | |
| 6 | 2011 | 5 | |
| 7 | 2011 | 5 | |
| 8 | 2011 | 113 | |
| 9 | 2008 | 47 | |
| 10 | 2007 | 169 | |
| 11 | National Committee for Clinical Laboratory Standards: Updates in Susceptibility Testing | 2004 | 1 |
| 12 | 2002 | 144 | |
| 13 | 2002 | 13 | |
| 14 | 2001 | 20 | |
| 15 | 2000 | 55 | |
| 16 | 1998 | 134 | |
| 17 | 1996 | 18 | |
| 18 | 1989 | 25 | |
| 19 | 1989 | 6 | |
| 20 | 1987 | 17 |
About Mary Jane Ferraro
Mary Jane Ferraro is a scholar working on Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 124 papers that have together received 30.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (48 papers), Antimicrobial Resistance in Staphylococcus (39 papers), Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Streptococcal Infections and Treatments (21 papers), Infective Endocarditis Diagnosis and Management (14 papers), Pneumonia and Respiratory Infections (12 papers) and Pharmaceutical and Antibiotic Environmental Impacts (8 papers). The work is most often cited by research in Molecular Medicine (9.8k citations), Applied Microbiology and Biotechnology (2.0k citations) and Clinical Biochemistry (5.4k citations). Mary Jane Ferraro has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include James H. Jorgensen, Kathryn L. Ruoff, George M. Eliopoulos, J H Jorgensen, Jana M. Swenson, Fred C. Tenover, Robert C. Moellering, John A. Branda, Christine Wennersten and L. Barth Reller. Their work appears in journals such as New England Journal of Medicine, The Lancet and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.